![Peter Bains](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Bains
Plus aucun poste en cours
Profil
Currently, Peter James Jonathan Bains is Group Chief Executive Officer at Biocon Biologics (Thailand) Co. Ltd., Biocon Biologics Switzerland AG, Biocon Biologics South Africa (Pty) Ltd., and Biocon Biologics Spain SLU.
He is Non-Executive Chairman at ILC Therapeutics Ltd., Chief Business Officer & Non-Executive Director at MiNA Therapeutics Ltd. since 2020, Director at Mina (Holdings) Ltd. since 2014, and Non-Executive Director at Apterna Ltd. Formerly, he was President, Chief Executive Officer & Director at Nxera Pharma Co., Ltd. from 2016 to 2018, Group Chief Executive Officer at Biocon Ltd. from 2023 to 2025, Chief Executive Officer, Executive Director & MD at Syngene International Ltd. from 2025 to 2026, Non-Executive Chairman at Fermenta Biotech Ltd. from 2010 to 2018, Non-Executive Director at Phase4 Partners Ltd., GlaxoSmithKline Pharmaceuticals Ltd., Syngene International Ltd. from 2016 to 2017, Independent Non-Executive Director at Kromek Group Plc in 2015, Director at Nxera Pharma UK Ltd., Director & Senior Vice President-Global Marketing at SmithKline Beecham Ltd., Director at Baines Peter Consulting, Independent Non-Executive Director at Mereo BioPharma Group Plc from 2015 to 2021, Director at Sosei R&D Ltd., Independent Non-Executive Director at Indivior Ltd. from 2019 to 2025, and SVP-International Commercial Development at GSK Plc.
Education includes an undergraduate degree from The University of Sheffield, conferred in 1979.
Dernières actualités sur Peter Bains
Postes actifs de Peter Bains
| Sociétés | Poste | Début |
|---|---|---|
MiNA Therapeutics Ltd.
 MiNA Therapeutics Ltd. BiotechnologyHealth Technology Develops biological and medical products | Directeur/Membre du Conseil | - |
Mina (Holdings) Ltd.
 Mina (Holdings) Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Directeur/Membre du Conseil | 17/12/2014 |
Apterna Ltd. | Directeur/Membre du Conseil | - |
ILC Therapeutics Ltd.
 ILC Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on biotechnology | Président | - |
Anciens postes connus de Peter Bains
| Sociétés | Poste | Fin |
|---|---|---|
| SYNGENE INTERNATIONAL LIMITED | Directeur Général | 30/06/2026 |
Indivior Ltd.
 Indivior Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical drugs | Directeur/Membre du Conseil | 08/05/2025 |
| BIOCON LIMITED | Directeur Général | 01/04/2025 |
Phase4 Partners Ltd.
 Phase4 Partners Ltd. Investment ManagersFinance Phase4 Ventures invests in companies located in the United Kingdom. The firm focuses on a broad range of sectors and industries. It Participates in early and later stage capital requirements with an investment size of USD 15 - 30 million. | Directeur/Membre du Conseil | 28/02/2022 |
| MEREO BIOPHARMA GROUP PLC | Directeur/Membre du Conseil | 20/09/2021 |
Formation de Peter Bains
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
54
Relations au 1er degré
19
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 19 |
|---|---|
Phase4 Partners Ltd.
Phase4 Partners Ltd. Investment ManagersFinance Phase4 Ventures invests in companies located in the United Kingdom. The firm focuses on a broad range of sectors and industries. It Participates in early and later stage capital requirements with an investment size of USD 15 - 30 million. | Finance |
Indivior Ltd.
Indivior Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical drugs | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
GlaxoSmithKline Pharmaceuticals Ltd.
 GlaxoSmithKline Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Engages in the business of manufacturing, distributing and trading in pharmaceuticals | Health Technology |
Biocon Ltd.
 Biocon Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals | Health Technology |
Sosei R&D Ltd.
 Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Fermenta Biotech Ltd. /Old/
 Fermenta Biotech Ltd. /Old/ BiotechnologyHealth Technology Manufactures biological products | Health Technology |
Syngene International Ltd.
 Syngene International Ltd. Miscellaneous Commercial ServicesCommercial Services Offers integrated discovery and development services | Commercial Services |
The University of Sheffield
 The University of Sheffield Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kromek Group Plc
 Kromek Group Plc Medical SpecialtiesHealth Technology Engages in the development of radiation detectors based on cadmium zinc telluride | Health Technology |
Nxera Pharma Co., Ltd.
 Nxera Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops bio pharmaceutical products | Health Technology |
Nxera Pharma UK Ltd.
 Nxera Pharma UK Ltd. Pharmaceuticals: MajorHealth Technology Designs and develops new medicines targeting G protein-coupled receptors | Health Technology |
SmithKline Beecham Ltd.
 SmithKline Beecham Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Baines Peter Consulting | |
MiNA Therapeutics Ltd.
MiNA Therapeutics Ltd. BiotechnologyHealth Technology Develops biological and medical products | Health Technology |
Mereo BioPharma Group Plc
 Mereo BioPharma Group Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Mina (Holdings) Ltd.
Mina (Holdings) Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
ILC Therapeutics Ltd.
ILC Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on biotechnology | Commercial Services |
Apterna Ltd. |
Choisissez Zonebourse 
